
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Walgreens Boots Alliance Inc (WBA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: WBA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $11.93
1 Year Target Price $11.93
2 | Strong Buy |
0 | Buy |
11 | Hold |
0 | Sell |
1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -41.55% | Avg. Invested days 24 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 10.37B USD | Price to earnings Ratio - | 1Y Target Price 11.93 |
Price to earnings Ratio - | 1Y Target Price 11.93 | ||
Volume (30-day avg) 14 | Beta 0.77 | 52 Weeks Range 7.98 - 13.25 | Updated Date 08/28/2025 |
52 Weeks Range 7.98 - 13.25 | Updated Date 08/28/2025 | ||
Dividends yield (FY) 4.19% | Basic EPS (TTM) -7.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.07% | Operating Margin (TTM) 0.74% |
Management Effectiveness
Return on Assets (TTM) 0.83% | Return on Equity (TTM) -69.58% |
Valuation
Trailing PE - | Forward PE 7.7 | Enterprise Value 38573416886 | Price to Sales(TTM) 0.07 |
Enterprise Value 38573416886 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 0.25 | Enterprise Value to EBITDA -22.57 | Shares Outstanding 865561024 | Shares Floating 716009102 |
Shares Outstanding 865561024 | Shares Floating 716009102 | ||
Percent Insiders 17.44 | Percent Institutions 60.94 |
Upturn AI SWOT
Walgreens Boots Alliance Inc

Company Overview
History and Background
Walgreens Boots Alliance Inc. (WBA) traces its roots back to 1901 when Charles Walgreen opened his first drugstore in Chicago. Over the decades, Walgreens expanded its retail footprint and diversified its offerings. In 2014, Walgreens merged with Alliance Boots, creating Walgreens Boots Alliance.
Core Business Areas
- U.S. Retail Pharmacy: Includes Walgreens and Duane Reade pharmacies across the United States, offering prescription services, health and wellness products, beauty products, and photo services.
- International: Encompasses Boots pharmacies and healthcare services primarily in the United Kingdom and Europe, as well as global wholesale and distribution.
- U.S. Healthcare: Provides technology-enabled healthcare solutions through Shields Health Solutions, VillageMD, and CareCentrix
Leadership and Structure
The CEO of Walgreens Boots Alliance is Tim Wentworth. The company operates with a hierarchical structure, dividing operations into the U.S. and International segments. The Board of Directors provides oversight and strategic guidance.
Top Products and Market Share
Key Offerings
- Prescription Medications: Walgreens is a major distributor of prescription drugs. Competition comes from CVS (CVS), Rite Aid (RAD), and Amazon Pharmacy (AMZN). No specific market share available.
- Health and Wellness Products: Includes over-the-counter medications, vitamins, and supplements. Competitors include Walmart (WMT), Target (TGT), and Amazon (AMZN). No specific market share available.
- Beauty Products: Cosmetics, skincare, and hair care products. Competitors include Sephora, Ulta Beauty, and department stores. No specific market share available.
Market Dynamics
Industry Overview
The retail pharmacy industry is facing increasing competition from online retailers and evolving healthcare models. Consolidation and vertical integration are key trends. Aging populations, increasing chronic diseases, and greater access to healthcare all affect the industry.
Positioning
Walgreens Boots Alliance is a major player in the retail pharmacy and healthcare sector, with a strong brand recognition and extensive network of stores. They compete on convenience, brand loyalty, and an integrated pharmacy/retail model.
Total Addressable Market (TAM)
The U.S. pharmacy market is projected to reach hundreds of billions of dollars. WBA is strongly positioned but facing growing competition from both brick and mortar stores such as CVS and online stores such as Amazon.
Upturn SWOT Analysis
Strengths
- Extensive Retail Footprint
- Strong Brand Recognition
- Established Pharmacy Network
- Strategic Partnerships (e.g., VillageMD)
Weaknesses
- High Debt Levels
- Declining Retail Sales
- Competitive Pressure
- Integration Challenges (Acquisitions)
Opportunities
- Expanding Healthcare Services
- Growing Online Presence
- Strategic Partnerships
- Aging Population
Threats
- Increased Competition
- Changing Healthcare Regulations
- Economic Downturn
- Supply Chain Disruptions
Competitors and Market Share
Key Competitors
- CVS (CVS)
- Rite Aid (RAD)
- Amazon (AMZN)
Competitive Landscape
Walgreens faces intense competition from CVS, which has a similar retail pharmacy model. Amazon is a growing threat with its online pharmacy. Walgreens differentiates itself through its strong brand recognition and strategic partnerships.
Major Acquisitions
Shields Health Solutions
- Year: 2021
- Acquisition Price (USD millions): 1375
- Strategic Rationale: Strengthens Walgreens' position in specialty pharmacy and expands its healthcare services capabilities.
Growth Trajectory and Initiatives
Historical Growth: Historical Growth information not available for public disclosure in this response.
Future Projections: Future Projections information not available for public disclosure in this response.
Recent Initiatives: Walgreens Boots Alliance has focused on expanding its healthcare services, including partnerships with VillageMD to open primary care clinics co-located with Walgreens stores. They have also invested in digital health solutions to improve patient engagement.
Summary
Walgreens Boots Alliance has an extensive retail footprint and a strong brand. It faces challenges including high debt and growing competition from online pharmacies. Expanding healthcare services represents a significant growth opportunity, but the company must adapt to evolving consumer preferences and regulatory changes. With a solid presence Walgreens Boots Alliance is still facing headwind issues such as debt and decline in retail sales.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Financial News Outlets
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Walgreens Boots Alliance Inc
Exchange NASDAQ | Headquaters Deerfield, IL, United States | ||
IPO Launch date 1985-07-01 | CEO & Director Mr. Timothy C. Wentworth | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 193000 | |
Full time employees 193000 |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.